Opening hours: Monday to Friday: 8:30am - 5:30pm Saturday: 8:30am - 12:30pm
contact@leehmeyecentre.com.sg
Call us at 6470 3366
  • English
  • 中文

Implantable Contact Lens (ICL)

Implantable Contact Lens (ICL)

What is an ICL?

ICL Picture

An ICL is similar to a contact lens, except it is placed inside the eye instead of worn outside. It is made of collamer material which consists of collagen and therefore is 100% compatible with the human body. Among collamer’s advantages are its anti-reflectivity and UV protection. The ICL is made to remain in the eye for a lifetime.

The ICL is invisible and the patient does not feel or see the lens once it is inside the eye. The only way that anyone knows an ICL is in place is the marked improvement in the eyesight.

The ICL is manufactured in Switzerland and is US FDA-approved with proven track record. To date, more than 375,000 lenses have been implanted worldwide.


How is an ICL procedure done?

It takes a short 15 minutes for the treatment and is done as a Day Surgery case. This reversible procedure is fast, precise and safe.

Prior to the implantation of the ICL, some anaesthetic eyedrops will be applied to minimize discomfort. The doctor then creates a micro opening on the cornea to insert the lens. As the ICL is tiny and soft, it can be folded and inserted painlessly into the eye. Once in the eye, the lens unfolds into position.

The incision does not need any sutures, it will seal naturally and heal in a short time. Most patients experience an immediate improvement in vision quality and can return to daily routine of activities the next day.


Who are good candidates for ICL?

The ICL has proven to be effective in patients within a wide range of refractive errors. It can treat up to -20D of myopia, +10D of hyperopia and -5D of astigmatism.

Prior to the development of the ICL technology, some individuals were not candidates for surgical eye correction. The results from an ICL treatment are predictable and stable because implantation of the lens does not require any structural alteration of the eye.

People who are pregnant or breast-feeding are not advised to undergo the ICL treatment. The refractive status (degree) of the eye should also be stable for the past 1 year.

The ICL treatment may not be suitable for everyone. As with all other treatments of the eye, the ICL carries risks including the need for a second surgery, temporary swelling or inflammation, cataracts, increases in eye pressure, retinal detachment, endothelial cell loss and reduced visual acuity.

Consult with the eye doctor to learn more about the ICL and possible complications.

The video below provides more information for people who are considering the ICL treatment. Further information can also be downloaded here.

The video above shows the ICL treatment